Gregory Charles Finnigan

Title: Gregory Charles Finnigan: Innovator in Genomic Editing

Introduction

Gregory Charles Finnigan is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genomic editing, particularly through his innovative methods and compositions. His work focuses on the development of genetically modified cells and non-human organisms, which have the potential to revolutionize genetic research and applications.

Latest Patents

Finnigan holds a patent for "Methods and compositions for genomic editing." This patent outlines the creation of genetically modified cells and organisms, detailing methods for producing these entities. The disclosure emphasizes the integration of heterologous nucleic acids, which include a CRISPR/Cas target sequence, into the genomes of these modified cells and organisms. This advancement allows for simultaneous gene editing at multiple positions within a genome using a single species of CRISPR/Cas guide RNA, enhancing the efficiency of genetic modifications.

Career Highlights

Finnigan is affiliated with the University of California, where he continues to advance his research in genomic editing. His work has garnered attention for its innovative approach to genetic engineering, contributing to the broader scientific community's understanding of genome manipulation.

Collaborations

One of his notable collaborators is Jeremy W. Thorner, with whom he has worked on various projects related to genomic editing. Their partnership exemplifies the collaborative nature of scientific research, particularly in cutting-edge fields like genetic engineering.

Conclusion

Gregory Charles Finnigan's contributions to genomic editing through his patented methods and compositions highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also paves the way for future innovations in genetic research.